Pisa Syndrome in Parkinson’s Disease: Pathogenic Roles of Verticality Perception Deficits
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pisa Syndrome in Parkinson’s Disease: Pathogenic Roles of Verticality Perception Deficits ; volume:8 ; number:1 ; day:29 ; month:1 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (29.1.2018), 1-9, 12.2018
- Creator
-
Huh, Young Eun
- Contributor
-
Kim, Kunhyun
Chung, Won-Ho
Youn, Jinyoung
Kim, Seonwoo
Cho, Jin Whan
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-20129-2
- URN
-
urn:nbn:de:1111-201804137790
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Huh, Young Eun
- Kim, Kunhyun
- Chung, Won-Ho
- Youn, Jinyoung
- Kim, Seonwoo
- Cho, Jin Whan
- SpringerLink (Online service)
Other Objects (12)
Modulating brain networks associated with cognitive deficits in Parkinson’s disease
Motor skill learning, retention, and control deficits in Parkinson´s disease
Continuous force measurements reveal no inhibitory control deficits in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Disentangling perceptual judgment and online feedback deficits in Parkinson’s freezing of gait
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease
Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment
Modulating brain networks associated with cognitive deficits in Parkinson’s disease
Motor skill learning, retention, and control deficits in Parkinson´s disease
Continuous force measurements reveal no inhibitory control deficits in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Disentangling perceptual judgment and online feedback deficits in Parkinson’s freezing of gait
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease
Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment
Modulating brain networks associated with cognitive deficits in Parkinson’s disease
Motor skill learning, retention, and control deficits in Parkinson´s disease
Continuous force measurements reveal no inhibitory control deficits in Parkinson’s disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Disentangling perceptual judgment and online feedback deficits in Parkinson’s freezing of gait
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease